• Health & Medicine

44% rise in patients waiting for tests to diagnose bowel, stomach, bladder and oesophageal cancer

55,500 more people are waiting to get tests used to diagnose four common cancers compared to last year. 55,500 more people are waiting to get tests used to diagnose four common cancers compared to last year.

20 July 2020

• Science & Technology
• Health & Medicine

News digest - smoking ban, HPV and prostate cancer, genetic testing and plain packaging

Smoking could be banned outsides pubs, cafés and restaurants in England, with peers urging ministers to consider similar measures in England. Smoking could be banned outsides pubs, cafés and restaurants in England, with peers urging ministers to consider similar measures in England.

18 July 2020

• Personal Stories

Coronavirus reports – Part 6: “The kids being home all the time has been quite a challenge”

We caught up with 3 people living with cancer to find out how the coronavirus pandemic has affected them and their families. We caught up with 3 people living with cancer to find out how the coronavirus pandemic has affected them and their families.

17 July 2020

• Health & Medicine

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.   The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

16 July 2020

• For Supporters

Brett Warburton: “It’s important to me to put something back into the communities where we live and work”

As British bakery brand Warburtons celebrates reaching £2m raised for cancer research, we hear from the company’s Executive Director, Brett Warburton As British bakery brand Warburtons celebrates reaching £2m raised for cancer research, we hear from the company’s Executive Director, Brett Warburton

16 July 2020

• Policy & Insight

COVID-19: “We’re having to rebuild and adapt because of coronavirus”

We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell. We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell.

15 July 2020

• Health & Medicine

Pursuing precision medicine in a flagship lung cancer trial

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

15 July 2020

• Charity News
• For Supporters

Cancer Research UK plans to rebuild and adapt to changed world following £300m drop in income

Cancer Research UK is making difficult decisions to significantly reduce how much it spends on beating cancer, its operations and the number of staff. Cancer Research UK is making difficult decisions to significantly reduce how much it spends on beating cancer, its operations and the number of staff.

15 July 2020

• For Researchers

The power of genomic cancer data

We're working with Public Health England to promote the collection and usage of genomic cancer data; the National Lung Matrix Trial highlights the benefits. We're working with Public Health England to promote the collection and usage of genomic cancer data; the National Lung Matrix Trial highlights the benefits.

15 July 2020

• Health & Medicine
• Science & Technology

News digest – light-activated nanoparticles, Government's obesity plans, tumour 'glue' and AI research fund

Researchers are developing light-activated nanoparticles that can ‘rob’ cancer cells of vital survival proteins. Researchers are developing light-activated nanoparticles that can ‘rob’ cancer cells of vital survival proteins.

11 July 2020

• Health & Medicine

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England. The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

10 July 2020

• Policy & Insight
• Health & Medicine

Urgent cancer referrals being turned down during coronavirus pandemic 

Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic. Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.

8 July 2020